Announcements Trials
Browse Landscape

Phase

Phase 2 13Phase 1 8Phase 3 4Phase 4 1Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Colorectal Neoplasms 9Breast Neoplasms 5Neoplasms 3Neoplasm Metastasis 3Ovarian Neoplasms 2Liver Neoplasms 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Solid Tumor 1Proteinuria 1Peritoneal Neoplasms 1Non-Squamous Non-Small Cell Lung Cancer 1Locally Advanced Colorectal Cancer 1Fallopian Tube Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Biliary Tract Neoplasms 1

Interventions

olaparib 1niraparib 1liposomal doxorubicin 1fluciclovine F-18 1Paclitaxel 1Carboplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Carcinoma, Ovarian Epithelial × Bevacizumab × Clear all
NCT06121401 2025-09-17

IOLANTHE

Mario Negri Institute for Pharmacological Research

Phase 4 Active not recruiting
190 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡